Combinatorial approach to cancer immunotherapy: strength in numbers
AE Vilgelm, DB Johnson… - Journal of Leucocyte …, 2016 - academic.oup.com
Immune-checkpoint blockade therapy with antibodies targeting CTLA-4 and PD-1 has
revolutionized melanoma treatment by eliciting responses that can be remarkably durable …
revolutionized melanoma treatment by eliciting responses that can be remarkably durable …
Combinatorial approach to cancer immunotherapy: strength in numbers.
AE Vilgelm, DB Johnson, A Richmond - Journal of Leukocyte …, 2016 - europepmc.org
Immune-checkpoint blockade therapy with antibodies targeting CTLA-4 and PD-1 has
revolutionized melanoma treatment by eliciting responses that can be remarkably durable …
revolutionized melanoma treatment by eliciting responses that can be remarkably durable …
Combinatorial approach to cancer immunotherapy: strength in numbers
AE Vilgelm, DB Johnson… - Journal of Leukocyte …, 2016 - Wiley Online Library
Immune‐checkpoint blockade therapy with antibodies targeting CTLA‐4 and PD‐1 has
revolutionized melanoma treatment by eliciting responses that can be remarkably durable …
revolutionized melanoma treatment by eliciting responses that can be remarkably durable …
Combinatorial approach to cancer immunotherapy: strength in numbers
AE Vilgelm, DB Johnson, A Richmond - Journal of Leukocyte Biology, 2016 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Immune-checkpoint blockade therapy with
antibodies targeting CTLA-4 and PD-1 has revolutionized melanoma treatment by eliciting …
antibodies targeting CTLA-4 and PD-1 has revolutionized melanoma treatment by eliciting …
Combinatorial approach to cancer immunotherapy: strength in numbers
AE Vilgelm, DB Johnson… - Journal of leukocyte …, 2016 - pubmed.ncbi.nlm.nih.gov
Immune-checkpoint blockade therapy with antibodies targeting CTLA-4 and PD-1 has
revolutionized melanoma treatment by eliciting responses that can be remarkably durable …
revolutionized melanoma treatment by eliciting responses that can be remarkably durable …
Combinatorial approach to cancer immunotherapy: Strength in numbers
AE Vilgelm, DB Johnson… - Journal of Leukocyte …, 2016 - ohiostate.elsevierpure.com
Immune-checkpoint blockade therapy with antibodies targeting CTLA-4 and PD-1 has
revolutionized melanoma treatment by eliciting responses that can be remarkably durable …
revolutionized melanoma treatment by eliciting responses that can be remarkably durable …
[HTML][HTML] Combinatorial approach to cancer immunotherapy: strength in numbers
AE Vilgelm, DB Johnson… - Journal of Leukocyte …, 2016 - ncbi.nlm.nih.gov
Immune‐checkpoint blockade therapy with antibodies targeting CTLA‐4 and PD‐1 has
revolutionized melanoma treatment by eliciting responses that can be remarkably durable …
revolutionized melanoma treatment by eliciting responses that can be remarkably durable …
Combinatorial approach to cancer immunotherapy: strength in numbers.
AE Vilgelm, DB Johnson, A Richmond - Journal of Leukocyte …, 2016 - europepmc.org
Immune-checkpoint blockade therapy with antibodies targeting CTLA-4 and PD-1 has
revolutionized melanoma treatment by eliciting responses that can be remarkably durable …
revolutionized melanoma treatment by eliciting responses that can be remarkably durable …